Douglas Plassche sold $499k of ELTP
EVP Operations at ELITE PHARMACEUTICALS INC /NV/. 800,000 shares at an average of $0.62, traded Oct 2, 2025, filed Oct 3, 2025.
Score components
- +15RoleOfficer
- +18Trade size$499k at market
- +5Share of holdings soldSold 19% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.1%, 3m -21.9%, 6m -40.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-25-016979, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 2, 2025 | SOpen-market sale common stock | -800,000 | $0.62 | $499k | 3,500,000 | Oct 3, 2025 |
Related signals
Other insiders at ELITE PHARMACEUTICALS INC /NV/ and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | ELTPbuy ELITE PHARMACEUTICALS INC /NV/ | Barry H Dash director | $8,610 30,000 shares | +1% | |
| 18Weak | ELTPsell ELITE PHARMACEUTICALS INC /NV/ | Elite Pharmaceuticals Inc /nv/ EVP Operations | $262k 500,000 shares | -22% | |
| 31Weak | ELTPbuy ELITE PHARMACEUTICALS INC /NV/ | Kirko Kirkov Chief Commercial Officer | $9,640 16,366 shares | - | |
| 25Weak | ELTPsell ELITE PHARMACEUTICALS INC /NV/ | Douglas Plassche EVP Operations | $116k 200,000 shares | -8% | |
| 54Moderate | ELTPsell ELITE PHARMACEUTICALS INC /NV/ | Douglas Plassche SVP of Operations | $562k 1,133,932 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.